Fails in detection in tumor samples (samples DNA_1-3; FFPE_1-3) corresponded to two frameshift mutations in BRCA2 (variants 2 and 6) and a splicing alteration in BRCA1 (variant 4). This evidence concerns the gene BRCA1 and neoplasm.